The European Medicines Agency has recommended the approval of GSK's add-on drug to treat asthma and a chronic inflammatory ...

ImmunityBio (NASDAQ: IBRX), a leading immunotherapy company, announced today that the European Medicines Agency has ...

EMA issues positive opinion on Novo Nordisk's higher-dose Wegovy, supported by strong weight-loss data and ongoing reviews in ...

European legislators have reached a deal on a major rewrite of the region's pharma policies, pushing forward a framework ...

The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended five novel medicines for approval at its ...

Shares of ImmunityBio ticked higher after the company said the European Medicines Agency recommended granting a conditional marketing authorization for its treatment for non-muscle invasive bladder ...

The recommendation addresses a long-standing treatment gap for patients facing bladder removal after standard therapy fails.

The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability ...

There are currently no signs of antibiotic shortages this winter in Europe, following years of limited supplies during colder months, the European Medicines Agency (EMA) told Euronews. In January 2024 ...

Drugmakers that develop new antibiotics are set to benefit from longer market protection in Europe after the EU agreed Thursday to a wide-ranging reform of pharmaceutical rules seeking to boost ...